|
|
Article: Paradigm Genetics Receives Fast-Track Contract From National Institutes of Health for Liver Toxicity Research.
- Article from:
- PR Newswire
- Article date:
- June 21, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- Approval Further Validates Paradigm's Metabolomics Strategy -
Paradigm Genetics, Inc. , a biotechnology company, announced today that it has received a Small Business Innovation Research Phase I/II contract from the National Institute of Environmental Health Sciences, National Institutes of Health, entitled "Metabolomics and Pathway Linkage: Urine, Serum, and Liver." The Fast Track contract will support Paradigm's efforts to discover biochemicals in urine, serum and liver tissue that predict the early onset of drug-induced liver injury. "Fast Track" refers to a mechanism used by the NIH to expedite the decision and award of applications that have a high ...